Expression of HAX-1 in human colorectal cancer and its clinical significance

Tumor Biology

Volumn 35, Issue 2, 2014, Pages 1411-1415

  Wei, Xiao Jun ^a,b   Li, Shi Yong ^b   Yu, Bo ^b   Chen, Guang ^b   Du, Jun Feng ^b   Cai, Hui Yun ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

HAX 1; Immunohistochemistry; Prognosis; Real time quantitative PCR

Indexed keywords

HS1 ASSOCIATED PROTEIN X 1; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER TISSUE; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; CARCINOGENESIS; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS;

EID: 84898839703     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1194-0     Document Type: Article

References (22)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2012;62:10-29. doi:10.3322/caac.20138.
2. Huerta S. Recent advances in the molecular diagnosis and prognosis of colorectal cancer. Expert Rev Mol Diagn. 2008;8:277-88. doi:10.1586/14737159.8. 3.277. (Pubitemid 351724707)
3. Fadeel B, Grzybowska E. HAX-1: a multifunctional protein with emerging roles in human disease. Biochim Biophys Acta. 2009;1790:1139-48. doi:10.1016/j.bbagen.2009.06.004.
4. Chao JR, Parganas E, Boyd K, Hong CY, Opferman JT, Ihle JN. Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons. Nature. 2008;452:98-102. doi:10.1038/nature06604. (Pubitemid 351355088)
5. Sharp TV, Wang HW, Koumi A, Hollyman D, Endo Y, Ye H, et al. K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function. J Virol. 2002;76:802-16. doi:10.1128/JVI.76.2.802-816.2002. (Pubitemid 34033378)
6. Han Y, Chen YS, Liu Z, Bodyak N, Rigor D, Bisping E, et al. Overexpression of HAX-1 protects cardiac myocytes from apoptosis through caspase-9 inhibition. Circ Res. 2006;99:415-23. doi:10.1161/01.RES.0000237387. 05259.a5. (Pubitemid 44253698)
7. Cilenti L, Soundarapandian MM, Kyriazis GA, Stratico V, Singh S, Gupta S, et al. Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2 protease during cell death. J Biol Chem. 2004;279:50295-301. doi:10.1074/jbc.M406006200. (Pubitemid 39577845)
8. Lee AY, Lee Y, Park YK, Bae KH, Cho S. Lee do H, Park BC, Kang S, Park SG. HS 1-associated protein X-1 is cleaved by caspase-3 during apoptosis. Mol Cells. 2008;25:86-90. (Pubitemid 351611842)
9. Vafiadaki E, Arvanitis DA, Pagakis SN, Papalouka V, Sanoudou D, Kontrogianni-Konstantopoulos A, et al. The anti-apoptotic protein HAX-1 interacts with SERCA2 and regulates its protein levels to promote cell survival. Mol Biol Cell. 2009;20:306-18. doi:10.1091/mbc.E08-06-0587.
10. Yedavalli VS, Shih HM, Chiang YP, Lu CY, Chang LY, Chen MY, et al. Human immunodeficiency virus type 1 Vpr interacts with antiapoptotic mitochondrial protein HAX-1. J Virol. 2005;79:13735-46. doi:10.1128/JVI.79.21.13735-13746. 2005. (Pubitemid 41508185)
11. Shaw J, Kirshenbaum LA. HAX-1 represses postmitochondrial caspase-9 activation and cell death during hypoxia-reoxygenation. Circ Res. 2006;99:336-8. doi:10.1161/01.RES.0000239408.03169.94. (Pubitemid 44253685)
12. Ramsay AG, Keppler MD, Jazayeri M, Thomas GJ, Parsons M, Violette S, et al. HS1-associated protein X-1 regulates carcinoma cell migration and invasion via clathrin-mediated endocytosis of integrin alphavbeta6. Cancer Res. 2007;67:5275-84. doi:10.1158/0008-5472.CAN-07-0318. (Pubitemid 46997266)
13. Radhika V, Onesime D, Ha JH, Dhanasekaran N. Galpha13 stimulates cell migration through cortactin-interacting protein Hax-1. J Biol Chem. 2004;279:49406-13. doi:10.1074/jbc.M408836200. (Pubitemid 39625826)
14. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia. 2004;6:1-6. (Pubitemid 38391943)
15. Jiang Y, Zhang W, Kondo K, Klco JM, St Martin TB, Dufault MR, et al. Gene expression profiling in a renal cell carcinoma cell line: dissecting VHL and hypoxia-dependent pathways. Mol Cancer Res. 2003;1:453-62. (Pubitemid 36459256)
16. Mirmohammadsadegh A, Tartler U, Michel G, Baer A, Walz M, Wolf R, et al. HAX-1, identified by differential display reverse transcription polymerase chain reaction, is overexpressed in lesional psoriasis. J Invest Dermatol. 2003;120:1045-51. doi:10.1046/j.1523-1747.2003.12247.x. (Pubitemid 36702916)
17. Trebinska A, Rembiszewska A, Ciosek K, Ptaszynski K, Rowinski S, Kupryjanczyk J, et al. HAX-1 overexpression, splicing and cellular localization in tumors. BMC Cancer. 2010;10:76. doi:10.1186/1471-2407-10-76.
18. Banerjee A, Saito K, Meyer K, Banerjee S, Ait-Goughoulte M, Ray RB, et al. Hepatitis C virus core protein and cellular protein HAX-1 promote 5-fluorouracil-mediated hepatocyte growth inhibition. J Virol. 2009;83:9663-71. doi:10.1128/JVI.00872-09.
19. Li M, Tang Y, Zang W, Xuan X, Wang N, Ma Y, et al. Analysis of HAX-1 gene expression in esophageal squamous cell carcinoma. Diagn Pathol. 2013;8:47. doi:10.1186/1746-1596-8-47.
20. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3:1101-8. (Pubitemid 351818697)
21. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108. (Pubitemid 40372904)
22. Compton CC, Greene FL. The staging of colorectal cancer: 2004 and beyond. CA Cancer J Clin. 2004;54:295-308. (Pubitemid 40073988)